AB | BC | MB | NB | NL | NS | NT | ON | PE | QC | SK | YT
Search National Drug Schedules Member Login

What's New

News Release / Communique de presse

NAPRA Welcomes Adele Fifield as New Executive Director /
L'ANORP souhaite la bienvenue à sa nouvelle directrice générale, Adele Fifield 

News Release / Communiqué de presse 

Pharmacy Technician Bridging Education Program-Course and PLAR exam schedules

Please note, this section will be updated periodically as the information becomes available.

 

  Reminder: Courses and PLAR exams available in both English and French

    NOTE: Selkirk College registration deadline for all English and French courses beginning in September 2016 is August 25, 2016

____________________________
 

        Rappel :  Les cours et les examens ERA sont offerts en français et en anglais

  REMARQUE :  La date limite pour l’inscription aux cours (anglais et français) débutant en septembre 2016 au collège Selkirk est le 25 août 2016 

Registration deadlines for all institutions are available on the Course and PLAR Schedules page.

Registration for all courses is conducted directly with the educational institution offering the program.

Health Canada Advisory

Expanded recall: All lots of "Rapidcuts Shredded" capsules recalled due to undeclared prescription drug

Further to a recent advisory, Health Canada is informing Canadians that Healthy Body Services Inc. is expanding its voluntary recall of Allmax-brand “Rapidcuts Shredded” capsules (NPN 80041658). All lots are now being recalled as a precaution after certain lots were found to contain an undeclared prescription drug (yohimbine hydrochloride).

Health Canada Advisory

Health Product Risk Communication

Zarontin (ethosuximide) - Defective Capsules Associated with Reduced Efficacy (Increased Frequency of Seizures) - Erfa Canada 2012 Inc.

Erfa Canada 2012 Inc. and Health Canada have received reports of broken or leaking Zarontin soft gel capsules. Administration of defective Zarontin soft gel capsules can be associated with a lack of efficacy (increased frequency of seizures).

Health Canada Health Product Risk Communication

Advisory

Recall of Rapidcuts "Shredded" capsules due to undeclared prescription drug

Health Canada is advising Canadians that Healthy Body Services Inc. has initiated a voluntary recall of two lots (G4016A and G4016) of Allmax-brand “Rapidcuts Shredded” capsules (NPN 80041658) because the product contains a prescription drug (yohimbine hydrochloride) not listed on the label. Taking a prescription drug unknowingly and without the supervision of a healthcare professional can pose serious health risks. The product is promoted as a work-out stimulant and fat-burner, and is sold at various retail outlets across Canada.

Health Canada Advisory

Information Update

Stronger, clearer labels for over-the-counter acetaminophen products to further address the risk of liver damage

Health Canada is releasing an updated Labelling Standard for over-the-counter acetaminophen products to help consumers use these products more safely. Product packages will include clearer instructions and stronger warnings to help reduce the potential for liver damage. This change is one of a number of steps Health Canada is taking in light of a safety review released in 2015.

Health Canada Information Update

Advisory

Unauthorized product “Black Orange” seized from Keebo Sports Supplements in Regina may pose serious health risks

Health Canada seized an unauthorized product called “Black Orange” from Keebo Sports Supplements at 2101 Quance St., Regina, Saskatchewan. The product is sold as a pre-workout stimulant and is labelled to contain ingredients that can pose serious health risks (yohimbine HCl, a prescription drug, and the combination of ephedrine and caffeine).

Health Canada Advisory

Information Update

Health Canada reinforces the importance of preventing pregnancy while taking the acne drug isotretinoin to avoid birth defects

Health Canada is reminding Canadians of the serious risk of birth defects associated with taking the prescription acne drug isotretinoin while pregnant. Health professionals and women who are using, or considering using this drug are reminded of the importance of not getting pregnant while taking this treatment.

Health Canada Information Update

Health Product Risk Communication

REVOLADE (eltrombopag) - Risk of Severe Hepatotoxicity - Novartis Pharma Canada Inc.

REVOLADE administration can cause severe hepatotoxicity and potentially fatal liver injury. Cases of severe drug-induced liver injury with REVOLADE have been reported in patients during clinical trials and post-marketing.

Health Canada Health Product Risk Communication

Health Product Risk Communication

PRIMAXIN 500 (imipenem and cilastatin sodium) for injection - Incorrect Labelling Information - Merck Canada Inc.

Imipenem and Cilastatin for Injection 500 mg/500 mg Single-Dose Vials - Incorrect Labelling Information - Hospira Healthcare Corporation, a Pfizer Company

There is incorrect information regarding the final diluted concentration after reconstitution on the label of the outer package of PRIMAXIN 500 (imipenem and cilastatin sodium) and the multi-vial carton of Imipenem and Cilastatin for Injection, 500 mg/500 mg. It indicates the diluted concentration is 2.5 mg/mL instead of 5 mg/mL (when prepared as per the instructions in the package insert). Referencing this incorrect information could lead to a potential dosing error.

Information Update

Sage Products recalls topical skin protectant cloths (dimethicone 3%) and topical antiseptic cloths (chlorhexidine gluconate 2%) due to possible microbial contamination

Health Canada is advising Canadians of a voluntary recall of some lots of various Sage brand single-use, pre-moistened disposable cloths used for cleansing or protecting skin, due to possible contamination with the bacteria Burkholderia cepacia (B.cepacia).

Health Canada Information Update

 

NOW AVAILABLE!
SITE MAINTENANT DISPONIBLE!

Gateway for international
pharmacists
Portail pour pharmaciens
formés à l’étranger

 

 

 

National Pharmacy Technician Bridging Education Program

Students and educational institutions can find more information about NAPRA's newest program.


NDSAC Drug Scheduling Applications

Find information about the NDSAC process and how to prepare scheduling applications.